|
|
Kenya
|
CTD3564
|
BCEF-CV 250 TABLETS
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
PHARMAMED SOLUTION LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
H2016/CTD3565/548
|
BCEF CV 500 TABLETS
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
PHARMAMED SOLUTION LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
CTD3565
|
BCEF CV 500 TABLETS
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
EUROPA HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2016/CTD3566/531
|
BCEF CV POWDER FOR ORAL SUSPENSION
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
PHARMAMED SOLUTION LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
CTD 3566
|
BCEF CV POWDER FOR ORAL SUSPENSION
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
EUROPA HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
Kenya
|
CTD3567
|
BCEF-CV DS POWDER FOR ORAL SUSPENSION
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
PHARMAMED SOLUTION LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
CTD 3567
|
BCEF-CV DS POWDER FOR ORAL SUSPENSION
|
CEFUROXIME AXETIL USP AND POTASSIUM CLAVULANATE DILUTED BP
|
EUROPA HEALTHCARE LTD
|
Registered
|
Details →
|